Monitor MiniMed's first standalone quarterly earnings for initial financial performance and guidance; the separation removes Medtronic overhang but also eliminates Medtronic's support; watch for any post-separation restructuring or capital structure changes.
Price Chart
Executive Summary
MiniMed completed its separation from Medtronic via an exchange offer, issuing 252,813,348 new shares of common stock in exchange for 55,032,401 Medtronic ordinary shares. Medtronic no longer holds any equity stake in MiniMed, and four Medtronic-appointed directors resigned from the board, with one new independent director appointed. This marks MiniMed's first day as a fully independent company.
Key Facts
- Exchange offer completed on October 15, 2026; 252,813,348 newly issued MiniMed shares exchanged for 55,032,401 Medtronic ordinary shares.
- Medtronic no longer owns any shares of MiniMed common stock.
- Exchange offer was 5.4x subscribed.
- Four directors (Linnea Burman, Scott Cundy, Laura Mauri, Matthew R. Walter) resigned effective October 15, 2026.
- Board reduced from 11 to 8 members; Amy Bricker appointed as Class II director.
- Amy Bricker is EVP, Chief Enterprise Pharmacy Officer at Walgreen Co., with prior roles at CVS Health and Express Scripts.
- Non-Employee Director Compensation Policy amended to provide pro-rated RSU grants for directors appointed between annual meetings.
Financial Impact
No financial figures provided; 252,813,348 new shares issued; no cash consideration disclosed.
Risk Factors
- Newly independent company with no prior standalone public financial history; execution risk on operational independence.
- Potential overhang from 252.8M newly issued shares entering the market.
- Loss of Medtronic's operational and strategic backing.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-116441 |
| Document: tm2627653d1_ex99-1.htm | 0001104659-26-116441 |
| Document: 0001104659-26-116441-index-headers.html | 0001104659-26-116441 |
| Document: 0001104659-26-116441-index.html | 0001104659-26-116441 |
| Document: 0001104659-26-116441.txt | 0001104659-26-116441 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | SC 13G | $18.34 | awaiting T+20 | — | $18.66 (+1.74%) |
Oct 16, 2026 10d ago | SC 13G/A | $17.79 | awaiting T+20 | — | $18.66 (+4.89%) |
Oct 16, 2026 10d ago | 8-K | $17.49 | awaiting T+20 | — | $18.66 (+6.69%) |
Oct 6, 2026 21d ago | EFFECT | $19.64 | awaiting T+20 | — | $18.66 (−4.99%) |
Oct 1, 2026 25d ago | 3 | $19.70 | awaiting T+20 | — | $18.66 (−5.28%) |
Sep 14, 2026 6w ago | 425 | $21.97 $18.80 | ▼ −14.43% | ▼ −16.69% | $18.66 (−15.07%) |
Sep 14, 2026 6w ago | 425 | $21.97 $18.80 | ▼ −14.43% | ▼ −16.69% | $18.66 (−15.07%) |
Sep 14, 2026 6w ago | 425 | $21.97 $18.80 | ▼ −14.43% | ▼ −16.69% | $18.66 (−15.07%) |
Sep 14, 2026 6w ago | 425 | $21.97 $18.80 | ▼ −14.43% | ▼ −16.69% | $18.66 (−15.07%) |
Sep 14, 2026 6w ago | 425 | $21.97 $18.80 | ▼ −14.43% | ▼ −16.69% | $18.66 (−15.07%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers